USANA Health Sciences amends credit facility, adds EBITDA covenant

USANA Health Sciences Inc. amended its revolving credit agreement, keeping the facility size at $75 million and maturity at June 27, 2030, while adding a new covenant requiring at least $100 million in trailing four-quarter consolidated EBITDA.